ChiCTR2600125216 版本V1.0 版本创建时间2026/05/22 14:15:40 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600125216 

最近更新日期:

Date of Last Refreshed on:

2026-05-22 14:15:23 

注册时间:

Date of Registration:

2026-05-22 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于呼吸音与胸部影像等多模态数据的慢阻肺病识别和评估的人工智能模型的建立与验证

Public title:

Establishment and Validation of an AI Model for COPD Identification and Assessment Based on Multimodal Data (Respiratory Sounds & Chest Imaging &Others)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于呼吸音与胸部影像等多模态数据的慢阻肺病识别和评估的人工智能模型的建立与验证

Scientific title:

Establishment and Validation of an AI Model for COPD Identification and Assessment Based on Multimodal Data (Respiratory Sounds & Chest Imaging & Others)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李强 

研究负责人:

李强 

Applicant:

Li Qiang 

Study leader:

Li Qiang 

申请注册联系人电话:

Applicant telephone:

+86 21 3880 4518

研究负责人电话:

Study leader's
telephone:

+86 21 3880 4518

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lqressh1962@163.com

研究负责人电子邮件:

Study leader's E-mail:

liqressh@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区即墨路150号

研究负责人通讯地址:

上海市浦东新区即墨路150号

Applicant address:

Pudong Area Jimo Road 150, Shanghai, China

Study leader's address:

150 Jimo Road, Pudong New Area, Shangha

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市东方医院

Applicant's institution:

Shanghai east hospital

研究负责人所在单位:

上海市东方医院

Affiliation of the Leader:

Shanghai East Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2025]研审第(089)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市东方医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai East Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-22 00:00:00

伦理委员会联系人:

萧王文

Contact Name of the ethic committee:

Xiao Wangwen

伦理委员会联系地址:

上海市浦东新区即墨路150号

Contact Address of the ethic committee:

150 Jimo Road, Pudong New Area, Shangha

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 38804518

伦理委员会联系人邮箱:

Contact email of the ethic committee:

xiaodwm@163.com

研究实施负责(组长)单位:

上海市东方医院

Primary sponsor:

Shanghai East Hospital

研究实施负责(组长)单位地址:

上海市浦东新区即墨路150号

Primary sponsor's address:

150 Jimo Road, Pudong New Area, Shangha

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市东方医院

具体地址:

上海市浦东新区即墨路150号

Institution
hospital:

Shanghai East Hospital

Address:

150 Jimo Road, Pudong New Area, Shangha

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-raised funds

研究疾病:

慢性阻塞性肺疾病  

Target disease:

Chronic obstructive pulmonary disease, COPD

研究疾病代码:

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

诊断试验诊断准确性 

Study design:

Diagnostic test for accuracy 

研究目的:

构建基于呼吸音气流特征、胸部 CT 影像及其他临床资料的多模态、深度学习、人工智能模型,并评价该模型识别和评估慢性阻塞性肺病的效能,包括准确率、灵敏度、特异度等多项指标。  

Objectives of Study:

Construct a multimodal, deep learning, artificial intelligence model based on respiratory sound airflow characteristics, chest CT images, and other clinical data. Evaluate the efficacy of this model in identifying and assessing chronic obstructive pulmonary disease, including multiple indicators such as accuracy, sensitivity, and specificity.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.男性或女性,年龄≥18岁,且≤80岁; 2.自行至多中心筛查点就诊,自愿参加本研究; 3.具有至少1次以上胸部CT影像检查影像及文字报告; 4.能够理解并完成肺功能检查操作; 5.受试者(或其监护人)能够理解研究目的,同意参加本研究并签署了知情同意书。

Inclusion criteria

1. Male or female, aged >= 18 years old and <= 80 years old; 2. Patients who visit the multi-center screening points on their own and voluntarily participate in this study; 3. Having at least one set of chest CT scan images and corresponding written reports; 4. Being able to understand and complete the pulmonary function test procedures; 5. The subject (or his/her guardian) is able to understand the purpose of the study, agrees to participate in this study and has signed the informed consent form.

排除标准:

1.数据大量缺失、可信度低者、无法配合研究流程者; 2.研究者认为不适合纳入者。

Exclusion criteria:

1. Those with a large amount of missing data, low data credibility, or who are unable to cooperate with the research process; 2. Those who are considered by the researchers to be unsuitable for inclusion.

研究实施时间:

Study execute time:

From 2025-07-01 00:00:00 To 2027-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-07-02 00:00:00 To 2027-12-31 00:00:00

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

肺功能检查

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

lung function test

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

基于呼吸音与胸部影像等多模态数据的人工智能模型

Index test:

Multimodal Artificial Intelligence Model Integrating Respiratory Sounds and Chest Imaging

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

慢性阻塞性肺疾病

例数:

Sample size:

500

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Chronic obstructive pulmonary disease

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

慢性支气管炎、哮喘等

例数:

Sample size:

100

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

Chronic bronchitis, asthma, etc.

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市东方医院 

单位级别:

三级甲等 

Institution
hospital:

Shanghai East Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

青岛大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Affiliated Hospital of Qingdao University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南省 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

湖南医药学院第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Hunan University of Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

准确率

指标类型:

主要指标

Outcome:

Accuracy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

灵敏度

指标类型:

次要指标

Outcome:

Sensitivity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

特异度

指标类型:

次要指标

Outcome:

Specificity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究公开发表后半年,邮件联系研究负责人合理获取。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the publication of the research, contact the research leader via email to obtain reasonable information.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-05-22 14:15:24